Song Lin

Song Lin is a seasoned professional in the field of drug metabolism and pharmacokinetics, currently serving as Senior Director of Clinical Pharmacology at Taiho Oncology, Inc. since January 2024, following the acquisition of Astex Pharmaceuticals. Prior experience includes significant roles such as Sr. Director of DMPK at Astex Pharmaceuticals, Director of Safety and DMPK at UNITY Biotechnology, and Director of DMPK at Alliance Pharma Inc., where responsibilities encompassed managing drug metabolism and pharmacokinetics in various drug discovery projects, conducting market analyses, and implementing business strategies. Earlier career milestones include serving as Investigator III and Metabolism Lab Head at Novartis Vaccine and Diagnostics and Principal Specialist at Chiron Corporation, both contributing to oncology and anti-infectious disease research. Song Lin holds a Master's degree in Folate and One Carbon Metabolism from the University of Alberta and another Master's degree in Anatomical Sciences from Zhongshan (Sun Yat-sen) University.